| Complement Overactivation and Consumption Predicts In-Hospital Mortality in SARS-CoV-2 Infection G Sinkovits, B Mező, M Réti, V Müller, Z Iványi, J Gál, L Gopcsa, ... Frontiers in Immunology 12, 866, 2021 | 104 | 2021 |
| Open ADAMTS13, induced by antibodies, is a biomarker for subclinical immune-mediated thrombotic thrombocytopenic purpura E Roose, AS Schelpe, E Tellier, G Sinkovits, BS Joly, C Dekimpe, ... Blood 136 (3), 353-361, 2020 | 78 | 2020 |
| Annual incidence and severity of acute episodes in hereditary thrombotic thrombocytopenic purpura E Tarasco, L Bütikofer, KD Friedman, JN George, I Hrachovinova, ... Blood, The Journal of the American Society of Hematology 137 (25), 3563-3575, 2021 | 45 | 2021 |
| Early increase in complement terminal pathway activation marker sC5b-9 is predictive for the development of thrombotic microangiopathy after stem cell transplantation O Horváth, K Kállay, D Csuka, B Mező, G Sinkovits, C Kassa, A Stréhn, ... Biology of Blood and Marrow Transplantation 24 (5), 989-996, 2018 | 39 | 2018 |
| Complement activation, inflammation and relative ADAMTS13 deficiency in secondary thrombotic microangiopathies P Farkas, D Csuka, B Mikes, G Sinkovits, M Réti, E Németh, K Rácz, ... Immunobiology 222 (2), 119-127, 2017 | 34 | 2017 |
| Decreased neutrophil extracellular trap degradation in Shiga toxin-associated haemolytic uraemic syndrome J Leffler, Z Prohászka, B Mikes, G Sinkovits, K Ciacma, P Farkas, M Réti, ... Journal of innate immunity 9 (1), 12-21, 2017 | 32 | 2017 |
| Concentration and subclass distribution of anti-ADAMTS13 IgG autoantibodies in different stages of acquired idiopathic thrombotic thrombocytopenic purpura G Sinkovits, Á Szilágyi, P Farkas, D Inotai, A Szilvási, A Tordai, K Rázsó, ... Frontiers in immunology 9, 1646, 2018 | 27 | 2018 |
| Class switch towards spike protein-specific IgG4 antibodies after SARS-CoV-2 mRNA vaccination depends on prior infection history P Kiszel, P Sík, J Miklós, E Kajdácsi, G Sinkovits, L Cervenak, ... Scientific Reports 13 (1), 13166, 2023 | 25 | 2023 |
| The role of human leukocyte antigen DRB1-DQB1 haplotypes in the susceptibility to acquired idiopathic thrombotic thrombocytopenic purpura G Sinkovits, Á Szilágyi, P Farkas, D Inotai, A Szilvási, A Tordai, K Rázsó, ... Human immunology 78 (2), 80-87, 2017 | 25 | 2017 |
| Elevated plasma neutrophil elastase concentration is associated with disease activity in patients with thrombotic thrombocytopenic purpura B Mikes, G Sinkovits, P Farkas, D Csuka, Á Schlammadinger, K Rázsó, ... Thrombosis research 133 (4), 616-621, 2014 | 25 | 2014 |
| Immunogenic hotspots in the spacer domain of ADAMTS13 in immune‐mediated thrombotic thrombocytopenic purpura LC Velasquez Pereira, E Roose, NAG Graça, G Sinkovits, K Kangro, ... Journal of Thrombosis and Haemostasis 19 (2), 478-488, 2021 | 21 | 2021 |
| Associations between the von Willebrand Factor—ADAMTS13 Axis, Complement Activation, and COVID-19 Severity and Mortality G Sinkovits, M Réti, V Müller, Z Iványi, J Gál, L Gopcsa, P Reményi, ... Thrombosis and Haemostasis, 2022 | 20 | 2022 |
| Anti-ADAMTS13 autoantibody profiling in patients with immune-mediated thrombotic thrombocytopenic purpura K Kangro, E Roose, BS Joly, G Sinkovits, T Falter, C von Auer, ... Blood advances 5 (17), 3427-3435, 2021 | 19 | 2021 |
| Validation of early increase in complement activation marker sC5b-9 as a predictive biomarker for the development of thrombotic microangiopathy after stem cell transplantation B Mező, O Horváth, G Sinkovits, N Veszeli, G Kriván, Z Prohaszka Frontiers in Medicine 7, 646, 2020 | 17 | 2020 |
| Platelet count, ADAMTS13 activity, von Willebrand factor level and survival in patients with colorectal cancer: 5-year follow-up study N Garam, É Maláti, G Sinkovits, T Gombos, A Szederjesi, L Barabás, ... Thrombosis and haemostasis 118 (01), 123-131, 2018 | 17 | 2018 |
| Complement lectin pathway activation is associated with COVID-19 disease severity, independent of MBL2 genotype subgroups L Hurler, Á Szilágyi, F Mescia, L Bergamaschi, B Mező, G Sinkovits, ... Frontiers in Immunology 14, 1395, 0 | 13 | |
| Evidence, detailed characterization and clinical context of complement activation in acute multisystem inflammatory syndrome in children G Sinkovits, J Schnur, L Hurler, P Kiszel, ZZ Prohászka, P Sík, E Kajdácsi, ... Scientific Reports 12 (1), 1-18, 2022 | 12 | 2022 |
| Decreased circulating dipeptidyl peptidase-4 enzyme activity is prognostic for severe outcomes in COVID-19 inpatients Á Nádasdi, G Sinkovits, I Bobek, B Lakatos, Z Förhécz, ZZ Prohászka, ... Biomarkers in Medicine 16 (5), 317-330, 2022 | 12 | 2022 |
| Distinction of early complement classical and lectin pathway activation via quantification of C1s/C1-INH and MASP-1/C1-INH complexes using novel ELISAs L Hurler, EJM Toonen, E Kajdácsi, B van Bree, RJ Brandwijk, W de Bruin, ... Frontiers in Immunology, 6384, 0 | 12 | |
| Elevated systemic pentraxin-3 is associated with complement consumption in the acute phase of thrombotic microangiopathies E Trojnar, M Józsi, Z Szabó, M Réti, P Farkas, K Kelen, GS Reusz, ... Frontiers in immunology 10, 240, 2019 | 6 | 2019 |
